Company
Rodin Therapeutics
- Status
- Acquiredas of 2026-09-17Source (opens in a new tab)
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
Rodin Therapeutics was a biotechnology company focused on discovering and developing first-in-class small molecule therapeutics. Acquired by ALKS in Nov 2019
About the company
- Status notes
- Acquired by ALKS in Nov 2019
Exit
- Acquisition
- 2019-11
Loading relationship preview